Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

(Reuters) - Paris prosecutors opened a criminal probe into Philips in June over its recall of sleep apnea devices, probing possible charges including aggravated fraud and failure to report safety ...

Sept 8 (Reuters) - Paris prosecutors opened a criminal probe into Philips (PHG.AS), opens new tab in June over its recall of sleep apnea devices, probing possible charges including aggravated fraud ...

Philadelphia, PA – The CPAP lawsuit, which has drawn national attention, is focused on CPAP, BiPAP, and ventilator devices, which are alleged to have produced potentially carcinogenic particles.

Technology company Philips plans to cut an estimated 5% of its workforce, about 4,000 positions, due to losses caused by the recall of a sleep apnea product as well as supply chain issues, according ...